好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Enhancing Traumatic Brain Injury Care Through A Point of Care Precision Medicine Dashboard: Stakeholder-Designed TBI BRIDGE
Neuro Trauma and Critical Care
P2 - Poster Session 2 (11:45 AM-12:45 PM)
3-007

To improve patient and care team experience in a concussion/traumatic brain injury (TBI) clinic, and to evolve TBI diagnosis and care models using a point-of-care precision medicine dashboard (BRIDGE). 

TBI symptom manifestations and recovery trajectories are heterogenous. Frontline ambulatory providers—including neurologists, primary care providers, neurosurgeons, rehabilitation therapists, and others—must navigate a large volume of injury-related information in the electronic health record (EHR) to provide tailored treatment aligned with evolving injury characterization and management frameworks. Patients must also digest this information to understand their recovery and treatment plans. BRIDGE is a technologically scalable digital health tool integrated within the EHR that can be adapted to specific clinical contexts to improve care delivery and clinical research.

A human-centered design framework was utilized for iterative design, refinement and implementation of TBI-BRIDGE. This included 5 phases: 1) study team knowledge sharing, 2) TBI-BRIDGE mock-up development, 3) qualitative evaluations of mock-ups, 4) TBI-BRIDGE development, and 5) TBI-BRIDGE implementation within clinics. 

During stages 1-3, 19 patients with TBI and 11 clinical team members (CTM) within local recovery clinics with representation from neurology, neuropsychology, occupational therapy, physical therapy, patient navigation, speech-language pathology, and physician trainees (neurology, neurosurgery), provided feedback. Regarding data visualization, patients provided more positive ratings toward TBI-BRIDGE mock-ups (17 positive responses, 1 negative response, 1 no response) compared to EHR visualizations (7 positive responses, 7 negative responses, 1 neutral response, 4 no response). Enhancement suggestions included longitudinal visualization of recovery progress (both groups) and injury features (CTM). Perceived utility included efficiency of visualizing injury, recovery, and plan information (both groups). 

All stakeholders, including nearly all patients surveyed, expressed greater enthusiasm for TBI-BRIDGE than for existing EHR data visualization tools for the care of TBI. TBI-BRIDGE can augment clinical encounters by streamlining access to actionable information to support data-driven, personalized care.

Authors/Disclosures
Cathra Halabi, MD (UCSF Department of Neurology)
PRESENTER
The institution of Dr. Halabi has received research support from UC Noyce Initiative. The institution of Dr. Halabi has received research support from Weill Institute for Neurosciences Neurohub. The institution of Dr. Halabi has received research support from NIH/NIDCD. The institution of Dr. Halabi has received research support from NIH/StrokeNet. Dr. Halabi has a non-compensated relationship as a Working Group Member with National Academies of Sciences, Engineering, and Medicine Action Collaborative on TBI Care that is relevant to AAN interests or activities. Dr. Halabi has a non-compensated relationship as a Working Group Member with NIH/StrokeNet Recovery and Rehabilitation Working Group that is relevant to AAN interests or activities.
Gina Gwiazda (University of California, San Francisco) Ms. Gwiazda has nothing to disclose.
Silke Miller, PhD Dr. Miller has received personal compensation for serving as an employee of Johnson and Johnson.
Narender Sara (University of California, San Francisco) No disclosure on file
Leila L. Etemad, BA Ms. Etemad has nothing to disclose.
Diego Martell Mr. Martell has nothing to disclose.
Gabriela G. Satris, RN Ms. Satris has nothing to disclose.
Geoffrey Manley, MD, PhD (UCSF Med Ctr/Dept of Neurosurgery) The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board.
Riley Bove, MD, FAAN (University of California, San Francisco) Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bove has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme-Sanofi. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Bove has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD-Serono. Dr. Bove has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadenza. The institution of Dr. Bove has received research support from Biogen. The institution of Dr. Bove has received research support from Eli Lilly. The institution of Dr. Bove has received research support from Novartis. The institution of Dr. Bove has received research support from Roche Genentech.